Posture
expanding
Deploying its record cash for the first time in years under new CEO Abel — OxyChem $9.7B (Jan 2026), Taylor Morrison $6.8B (May 2026), $10B Alphabet placement (Jun 2026).
Sourced figures 1
- Wikipedia — Berkshire Hathaway (recent corporate actions) Greg Abel succeeded Buffett as CEO at start of 2026; OxyChem acquired for $9.7B (Jan 2026); Taylor Morrison $6.8B (May 2026, pending); $10B Alphabet private placement (Jun 1 2026)
the working
Basis
Deploying its record cash for the first time in years under new CEO Abel — OxyChem $9.7B (Jan 2026), Taylor Morrison $6.8B (May 2026), $10B Alphabet placement (Jun 2026).
Threads 0
No thread tagged to this actor yet.
A claim is one metric we assert about a node — the value is the summary, this page is the receipt. Sourced from kestrel; supersedes-history not yet shown. Back to Berkshire Hathaway.